Zoe Lewczak is currently a Bioethics student at Harvard Medical School and also works for NYU Grossman School of Medicine on the Clinical Science Core (CSC) of NIH RECOVER. NYU serves as the scientific leadership and operational backbone of the RECOVER Initiative, set up to better understand post-acute sequelae of SARS-CoV-2 infection, known as Long COVID. While studying at the University of Virginia, Lewczak began focusing on cognitive science with a concentration in the neuroscience field. Eventually, she found her passion through the intersection of medicine and moral development in the field of bioethics. As a teen, she spent years working on an anti-tobacco campaign, where she found an interest in behavior change marketing, health advocacy, and policy. Her work led to the passing of HB 2384 and SB 1295 in Virginia's legislation banning tobacco and e-cigarette products on all school property. As an aspiring physician-ethicist, Lewczak envisions a future dedicated to advancing the field of ethics as both a clinician and researcher.